Acute and chronic administration of the selective sigma(1) receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
Y. Minabe et al., Acute and chronic administration of the selective sigma(1) receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study, SYNAPSE, 33(2), 1999, pp. 129-140
In this study, we examined the effect of the acute and repeated administrat
ion of the selective sigma (sigma)(1) receptor agonist 1-(3,4-dimethoxyphen
ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (SA4503) on the number
and firing pattern of spontaneously active dopamine (DA) neurons in substan
tia nigra pars compacta (SNC) and ventral tegmental area (VTA) in anestheti
zed, male Sprague-Dawley rats. This was accomplished using the technique of
in vivo extracellular single unit recording. The intravenous administratio
n of SA4503 (0.01-1.28 mg/kg) did not significantly alter the firing rate o
r pattern of spontaneously active DA neurons in either the SNC or VTA. A si
ngle injection of either 0.1 or 0.3 mg/kg i.p, of SA4503 did not alter the
number of spontaneously active SNC and VTA DA neurons. In contrast, a singl
e injection of 1 mg/kg i.p. of SA4503 produced a significant decrease and i
ncrease in the number of spontaneously active SNC and VTA DA neurons, respe
ctively. Overall, the firing pattern parameters of spontaneously active SNC
DA neurons were altered more significantly than those of spontaneously act
ive VTA DA neurons following the acute administration of SA4503. The repeat
ed administration (one injection per day for 21 days) of 0.3 and 1 mg/kg i.
p. of SA4503 produced a significant increase in the number of spontaneously
active VTA DA neurons. In addition, the repeated administration of SA4503
produced a greater alteration of the firing pattern of spontaneously active
VTA compared to SNC DA neurons. Our results suggest that the administratio
n of SA4503 significantly alters the activity of spontaneously active midbr
ain DA neurons, particularly those in the VTA following repeated administra
tion. (C) 1999 Wiley-Liss, Inc.